October 2026Leveraging large language models to characterize serious illness conversations in advanced non-small cell lung cancerPublication summaryPublicationsMachine learningNon-small cell lung cancerArtificial intelligence
October 2026Quality of care in US community oncology practices among patients with metastatic breast cancer and metastatic non-small cell lung cancerPublication summaryPublicationsBreast cancerNon-small cell lung cancerCommunity oncology
October 2026Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancerPublication summaryPublicationsProstate CancerTreatment and Testing patterns
September 2026Real-world outcomes of acute myeloid leukemia patients undergoing treatment with tyrosine kinase inhibitor (TKI) therapy targeting FLT3, IDH1, or IDH2Real-World EvidencePublication summaryPublicationsAcute myeloid leukemia
August 2026Recommendations for generating real-world evidence with regulatory-grade relevance and reliabilityReal-World EvidencePublication summaryPublicationsRegulatory
August 2026Real-world treatment duration and outcomes among patients with early-stage NSCLC receiving adjuvant osimertinib: a retrospective cohort studyPublication summaryPublicationsNon-small cell lung cancer
August 2026Genomic alterations without approved 1L targeted therapies in patients with NSCLC PD-L1 ≥50% treated with immunotherapyPublication summaryPublicationsNon-small cell lung cancerMolecular data
August 2026Real-world outcomes with chemoradiation and durvalumab consolidation in stage III KRAS G12C-mutant NSCLC in the USPublication summaryPublicationsNon-small cell lung cancer
August 2026Beyond the clinical trial: real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLCPublication summaryPublicationsNon-small cell lung cancer